Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
April 26, 2023 at 11:49 am
Share
Chempartner Pharmatech Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 268.66 million compared to CNY 386.3 million a year ago. Revenue was CNY 268.66 million compared to CNY 386.3 million a year ago.
Net loss was CNY 28.57 million compared to net income of CNY 9.47 million a year ago. Basic loss per share from continuing operations was CNY 0.0574 compared to basic earnings per share from continuing operations of CNY 0.019 a year ago. Diluted loss per share from continuing operations was CNY 0.0574 compared to diluted earnings per share from continuing operations of CNY 0.019 a year ago.
ChemPartner PharmaTech Co Ltd, formerly Quantum Hi-tech China Biological Co Ltd, is a China-based company principally engaged in the research, development, production, and sales of fructooligosaccharides and other prebiotics. The Company's main products include fructooligosaccharides and galactooligosaccharides. The Company owns brands names of FOS and GOS. The Company's products are mainly used in nutrition and health products, dairy products, beverages, baked goods, functional candy and snack foods. The Company distributes its products mainly in domestic market, with South China as its main market.